FINHUB Insights

CAH · Q1 FY26 · Jul 1 – Sep 30, 2025

Cardinal Health Q1 FY26: where the revenue came from and where it went

Cardinal Health Q1 FY26: revenue $64.0B (+22% year over year). Net profit $0.5B. Largest cohort Pharmaceutical and Specialty $59.2B. The whole income statement as a sankey diagram from the SEC filing.

Period
Jul 1 – Sep 30, 2025
Reported
Oct 30, 2025 10-Q
Sankey diagram of Cardinal Health's income statement for Q1 FY26: revenue of $64.00 billion splits into segments and flows out into costs, taxes and net profit.

Tap the diagram to enlarge · figures in billions of dollars

Revenue$64.00B +22% year over year
Gross profit$2.30B 4% margin
Operating profit$0.70B 1% margin
Net profit$0.50B 1% margin

The numbers

All figures in billions of U.S. dollars, for Q1 FY26 (period ends Sep 30, 2025).
ItemValueShare of revenueYear over year
Revenue 64.00 100% +22%
Pharmaceutical and Specialty 59.20 92% +23%
GMPD 3.20 5% +2%
All Other Segments 1.60 2% +38%
Cost of revenue−61.7096%
Gross profit2.304% margin+0pp
SG&A−1.502%+0pp
Other−0.200%+0pp
Operating profit0.701% margin+0pp
Tax−0.10
Interest & other costs−0.10
Net profit0.501%+0pp
Filing on EDGAR More quarters of CAH

Source of the numbers: structured XBRL data from the filing (10-Q). The diagram is generated automatically and checked against EDGAR before release. How we calculate it → About and methodology.

Older quarters